L&G Healthcare Technology & Innovation UCITS ETF (LON:DOCT)
London · Delayed Price · Currency is GBP · Price in USD 13.90
-0.09 (-0.65%)
Apr 2, 2026, 4:27 PM GMT
24.33% (1Y)
| Assets | 143.51M |
| Expense Ratio | 0.49% |
| PE Ratio | 24.90 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +25.51% |
| Volume | 660 |
| Open | 13.42 |
| Previous Close | 13.99 |
| Day's Range | 13.42 - 13.98 |
| 52-Week Low | 9.75 |
| 52-Week High | 16.15 |
| Beta | 1.33 |
| Holdings | 61 |
| Inception Date | Jun 17, 2019 |
About DOCT
L&G Healthcare Technology & Innovation UCITS ETF is headquartered in London, Greater London, United Kingdom.
Asset Class Equity
Category Health Care
Stock Exchange London Stock Exchange
Ticker Symbol DOCT
Provider L&G
Index Tracked ROBO Global Healthcare Technology and Innovation ETF
Performance
DOCT had a total return of 25.51% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.86%.
Top 10 Holdings
21.02% of assets| Name | Symbol | Weight |
|---|---|---|
| Axogen, Inc. | AXGN | 2.40% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.16% |
| Vertex Pharmaceuticals Incorporated | VRTX | 2.12% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 2.11% |
| Thermo Fisher Scientific Inc. | TMO | 2.09% |
| Guardant Health, Inc. | GH | 2.07% |
| Natera, Inc. | NTRA | 2.06% |
| Intuitive Surgical, Inc. | ISRG | 2.02% |
| Medpace Holdings, Inc. | MEDP | 1.99% |
| Regeneron Pharmaceuticals, Inc. | REGN | 1.99% |